Gainers Jin Medical International (NASDAQ:ZJYL) shares rose 58.1% to $3.4 during Monday's regul

Heron Therapeutics, Inc. (HRTX) Q2 2026 Earnings Call Transcript

Heron Therapeutics (HRTX) came out with a quarterly loss of $0.03 per share versus the Zacks Consens

Heron Therapeutics NASDAQ: HRTX reported second-quarter net revenue of $37.7 million, up from $34.7

CARY, N.C., July 27, 2026 (GLOBE NEWSWIRE) -- Heron Therapeutics, Inc. (Nasdaq: HRTX) (“Heron” or th

BV, RAIL and HRTX have been added to the Zacks Rank #5 (Strong Sell) List on July 15th, 2026.

Top Wall Street analysts changed outlook on top names. For all rating changes, upgrades and downgrad

CARY, N.C., June 02, 2026 (GLOBE NEWSWIRE) -- Heron Therapeutics, Inc. (Nasdaq: HRTX) (“Heron” or th

Heron Therapeutics, Inc. (HRTX) Q1 2026 Earnings Call Transcript

Heron Therapeutics NASDAQ: HRTX said first-quarter 2026 results were pressured by seasonal factors a

The headline numbers for Heron Therapeutics (HRTX) give insight into how the company performed in th

Heron Therapeutics (HRTX) came out with a quarterly loss of $0.04 per share versus the Zacks Consens

CARY, N.C., May 11, 2026 (GLOBE NEWSWIRE) -- Heron Therapeutics, Inc. (Nasdaq: HRTX) (“Heron” or the

Heron Therapeutics (HRTX) doesn't possess the right combination of the two key ingredients for a lik

CARY, N.C., April 27, 2026 (GLOBE NEWSWIRE) -- Heron Therapeutics, Inc. (Nasdaq: HRTX) (“Heron” or t

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should tak

Heron Therapeutics, Inc. (HRTX) Q4 2025 Earnings Call Transcript

While the top- and bottom-line numbers for Heron Therapeutics (HRTX) give a sense of how the busines

– ZYNRELEF ® and APONVIE ® Drive 65% Year-Over-Year Net Revenue Growth in Acute Care Franchise – Ach

HRTX has reported preliminary Q4'25 net revenues, with Zynrelef experiencing a breakout quarter. Apo

CARY, N.C., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Heron Therapeutics, Inc. (Nasdaq: HRTX) (“Heron” or th

New York State Common Retirement Fund raised its stake in Heron Therapeutics, Inc. (NASDAQ: HRTX) by

Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for it

Shares of LumiraDx Limited (NASDAQ: LMDX) shares fell sharply in pre-market trading. LumiraDx ann

Companies Reporting Before The Bell • CureVac (NASDAQ:CVAC) is likely to report quarterly loss at $

  On Tuesday, 647 companies set new 52-week lows.

  During Thursday's session, 406 companies made new 52-week lows.

  During the session on Thursday, 461 stocks hit new 52-week lows.

Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report q

  On Friday, 199 companies reached new 52-week lows.

Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings

  On Friday, 93 stocks made new 52-week lows.

  During Tuesday, 95 stocks hit new 52-week lows.

  On Friday, 469 companies hit new 52-week lows.

Companies Reporting Before The Bell • Adtran (NASDAQ:ADTN) is likely to report quarterly earnings a

  Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is estimated to repor

  During Monday's trading, 1214 companies set new 52-week lows.

  On Friday, 422 stocks made new 52-week lows.

  Monday's session saw 84 companies set new 52-week lows.